Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

SuperCom Ltd. (NASDAQ: SPCB) Announces ‘Breakthrough Performance’ with Q2 and H1 2023 Results

SuperCom (NASDAQ: SPCB), a global provider of traditional and digital identity solutions, providing advanced safety, identification, Internet of Things (“IoT”), connectivity, and security solutions to governments and private and public organizations globally, recently released its financial and operating results for the three and six months ended June 30, 2023, as well as financial highlights for […]

Alternative Products Expo: Pioneering the Counterculture Industry

Counterculture retail professionals, business executives, researchers, and industry leaders, are invited to attend Alternative Products Expo to be held in Las Vegas from September 14-16, 2023.  Dedicated to promoting creativity, the much-awaited event will be focused on eco-friendly solutions and alternative products. The Expo is set to engage audiences with a wide range of unique […]

GolfLync Inc. Innovates Again by Creating the World’s First Virtual Golf Clubs(TM)

GolfLync, the innovative social media networking platform designed exclusively for golf enthusiasts, is ushering in a new era for the golfing community with its groundbreaking feature, Virtual Golf Clubs(TM) (“VGC”). This cutting-edge addition to the app empowers golfers to connect, share experiences, and create thriving golfing communities, making GolfLync the go-to destination for passionate golfers […]

RVL Pharmaceuticals plc (NASDAQ: RVLP) Is ‘One to Watch’

RVL Pharmaceuticals (NASDAQ: RVLP) is a specialty pharmaceutical company focused on the commercialization of UPNEEQ(R) (oxymetazoline hydrochloride ophthalmic solution), 0.1%, which is available by prescription for the treatment of acquired blepharoptosis, or low-lying eyelid(s), in adults. UPNEEQ(R) (RVL-1201) is the first non-surgical treatment option approved by the U.S. Food and Drug Administration (FDA) for acquired […]

Renovaro BioSciences Inc. (NASDAQ: RENB), Immunotherapy Biotech Company, Announces Intention to Unite With AI Tech Developer GEDi Cube, Seen as Major Multiplier Effect in the Fight Against Cancer

The announcement of a binding and exclusive letter of intent to merge, between two of the most innovative companies in their respective fields, is seen as representing a potentially transformative step in the fight against cancer. Considering Renovaro BioSciences (NASDAQ: RENB), an advanced, pre-clinical biotechnology firm in cell, gene, and immunotherapy, that has already demonstrated […]

Electronic Servitor Publication Network Inc. (XESP) Committed to Improving Client Outcomes and Creating Shareholder Value

Electronic Servitor Publication Network (OTC: XESP), a market disruptor for B2B companies using advanced data analysis and smart technology, is driving up a unique value proposition to improve client outcomes. The company’s understanding of technology, its potential and its current role in facilitating positive customer relationships and influencing business growth has earned it a significant […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Affirms Product Superiority in Its 2023 Human Oral Nicotine Study, NIC-H22-1

Lexaria Bioscience Corp. (NASDAQ: LEXX), a global innovator in drug delivery platforms, just released results from its 2023 human oral nicotine study NIC-H22-1. Of note was its patented DehydraTECH(TM)–nicotine tobacco-free pouch product superiority, particularly when pitted against world-leading brands ZYN(R) and on!(R). The study proved that Lexaria’s product was statistically significantly faster than the two […]

Electronic Servitor Publication Network Inc. (XESP) Helping Companies Use Technology to Win Customers and Ensure End-to-End Customer Experiences

Customer experience is the process of measuring, analyzing, enhancing, and delivering superior customer interactions with a brand or business (https://ibn.fm/LC8zk). As such, companies need to pay attention to the full customer experience (“CX”) in order to unlock short-term profitability and also build long-term sustained advantage. This is seen as requiring a carefully crafted and orchestrated […]

Lexaria Bioscience Corp. (NASDAQ: LEXX) Announces Strategic Updates Concerning Patented DehydraTECH(TM) Technology

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, has announced updates regarding its patented DehydraTECH(TM) technology – which improves the way that active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. Lexaria’s primary focus for DehydraTECH research and development […]

Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Among Companies Leading Charge to Abate Reliance on Chinese Tech Metals Amid Ongoing Trade War

Restrictions imposed earlier this month by The People’s Republic of China on the export of two semiconductor metals represent the latest flashpoint in the years-long trade and technology war between the Asian nation and the United States and, in its development, a rationale for American production of resources critical to modern technology manufacturing. Some Western […]

 

From Our Blog

SS Innovations International, Inc. (NASDAQ: SSII) CEO Outlines Growth Strategy as SSi Mantra Expands Robotic Surgery, Telesurgery, and Global Reach

November 6, 2026

SS Innovations International (NASDAQ: SSII), a developer of innovative surgical robotic technologies, is seeing increased adoption of its SSi Mantra surgical robotic platform, with CEO Dr. Sudhir Srivastava telling The Motley Fool’s interviewer Rachel Warren that the company’s commercial growth reflects a combination of technological capabilities, clinical experience and affordability (https://ibn.fm/EJk05). During the interview, Srivastava […]

Rotate your device 90° to view site.